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Immunologic unresponsiveness has been induced in several species of neonatal 
or adult laboratory animals.  The maintenance  of this unresponsive state de- 
pends on the continued presence of a specific antigen (1-3). This tolerant state 
may be prolonged or accentuated when animals  are irradiated  shortly before 
introduction  of  the  tolerance-inducing  antigen  (4,  5).  Also,  animals  "over- 
loaded" with large doses of polysaccharide (6) or protein (5) do not respond to 
a later sensitization with the specific antigen. Unresponsiveness can be induced 
in guinea pigs by introduction of a hapten directly into the adult stomach (7, 
8) or by injection of a  protein into the fetus (9-11).  Finally,  administration 
of such antimetabolites as 6-mercaptopurine or cyclophosphamide in the pres- 
ence of specific antigen  induces unresponsiveness to that  antigen  (12,  13). 
Since the criterion of tolerance has usually been the inability of an animal 
to produce circulating  antibody, the specificity of tolerance often is presumed 
to follow the same determinants of the antigen as does the molecule of circu- 
lating antibody (2). Tolerance, however, applies to the suppression  not only of 
circulating  precipitating  antibody but also of non-precipitating  antibody (2), 
contact hypersensitivity to simple chemicals  (7), and delayed hypersensitivity 
to proteins  (11-13). 
The  specificity of delayed hypersensitivity has  been shown to differ  from 
that  of circulating  antibody (14--16). Sensitization  with conjugates,  such as 
p-aminobenzoic acid coupled to hen egg albumin, is followed by delayed hyper- 
sensitivity directed essentially to the protein carrier,  and later by circulating 
antibodies  to  smaller  groupings,  as  exemplified  by the  hapten.  Since  unre- 
sponsiveness applies both to delayed hypersensitivity and circulating  antibody 
and since these two phenomena have different specificities, the question arises 
as to the specificity of immunologic  unresponsiveness.  In recent studies with 
contact haptens, guinea pigs made unresponsive to the contact hapten dinitro- 
851 852  SPECIFICITY OF  ALLERGIC REACTIONS. VII 
fluorobenzene (DFB) 1 by "gastric feeding" had this unresponsiveness modified 
when the animals were subsequently sensitized with the hapten conjugated to a 
heterologous protein, such as hen egg albumin (HEA) (3). Antibody to the DFB 
appeared in  the  "tolerant"  guinea  pigs,  although  they still did not  react  to 
contact testing with the specific hapten. These seemingly contradictory results 
can  be  explained  if  the  specificity of unresponsiveness,  like  that  of delayed 
hypersensitivity, is directed primarily toward the protein,  in  contrast to the 
reactions of circulating antibody which are oriented toward smaller antigenic 
configurations.  Experiments  were  therefore  initiated  to  examine  further  the 
specificity of unresponsiveness.  The  present paper  offers data which  indicate 
that unresponsiveness to protein conjugates induced in guinea pigs by simul- 
taneous  treatment  with  cyclophosphamide and  antigen  has  its specificity di- 
rected  toward  the  entire  antigen  molecule. 
Materials and Methods 
Animals.--GuJnea pigs of the Hartley strain, 350 to 400 gm wt at the start of the experi- 
ments, were employed for the induction of tolerance against the "y-globulins.  Adult rabbits and 
guinea pigs were used for hyperimmtmization. 
Antigens.--Bovine gamma globulin (BGG) from Armour and Company, Chicago was used 
primarily in the studies on tolerance, although 5 times recrystallized  hen egg albumin (ttEA) 
from K  & K Laboratories Inc., Jamaica, New York, was also tried. The gamma globulins of 
pig, sheep, horse, and goat were prepared from fresh serum by precipitation from tmbuffered 
40 per cent saturated ammonium sulfate followed by purification with DEAE (cellulose N,N- 
diethylaminoethyl  ether, Eastman Organic Chemicals, Rochester New York). A given volume 
of serum was diluted with one-half volume of distilled water and mixed with one volume of 
ammonium  sulfate solution saturated at room temperature. The precipitate was dissolved in 
distilled water, precipitated twice more in the same way, and dialyzed against 0.01 M phos- 
phate buffer, pH 7.0. The precipitated euglobullns were removed by centrifugation,  and the 
supernatants were passed repeatedly through columns of DEAE until the effluents produced 
a  single sharp band after electruphoresis  on cellulose acetate strips. The same DEAE was 
never reused for purification  of globulins from different species. The final products were the 
proteins which had not been retained on the columns in 0.01 M phosphate.  Other fractions 
(referred to as "X-globulins") were eluted with NaCI up to 0.1 ~ and used to produce hyper- 
immune rabbit serum for studies on the purity of the "),-globulins.  The purified fractions were 
lyophillzed and stored at 4°C. 
Conjugates of BGG, HEA, HuSA, and similar proteins were prepared by diazotization of 
the hapten and coupling to the protein (16). Two #moles of diazotized hapten were used for 
each mg of protein. The products were precipitated by acidification with 10 per cent trichloro- 
acetic acid (TCA) to pH 3.0 and allowed to remain in TCA solution  overnight in the cold. 
The precipitate  was redlssolved by neutralization and dialyzed  several days against physiologic 
saline. 
1  BGG,  bovine  gamma globulin;  BSA,  bovine serum  albumin; BSP,  bromsulphthalein; 
DCB,  dinitrochlorobenzene;  DEAE, cellulose N,N-diethylaminoethyl ether; DFB, dinitro- 
fluorobenzene;  GGG, goat gamma globulin;  HEA, hen egg albumin; HoGG, horse gamma 
globulin;  HuSA,  human  serum albumin; PAAA, p-aminobenzene  arsonic acid; PABA, p- 
aminobenzoic acid; PASA, p-aminobenzene sulfonic acid; PCA, passive cutaneous anaphylaxis; 
PGG, pig gamma globulin; SGG, sheep gamma globulin; TCA, trichloroacetic  acid. S.  B.  SALVIN  AND  R.  ~'.  SMITH  853 
The amount of hapten in the conjugates was determined by use of Cl~-labeled  PABA for 
the  preparation  of  PABA.BGG,  PABA.HuSA,  and  PABA.HEA.  After  passage  through 
sephadex G-25, followed by dialysis, the hapten content of the conjugate was determined in a 
liquid scintillation counter, and the protein, by the Kjeldahl method.  Since all azo nitrogen 
may not be detected by the Kjeldahl method, its reliability for conjugates was checked by 
comparison with protein concentrations obtained by drying HEA and conjugates to constant 
weight in a vacuum oven at 100°C.  15.5 per cent was used for the nitrogen content of HEA. 
For PABA.HEA and PABA.BGG containing 10 per cent hapten, the nitrogen content was 
14.4 4- 0.1 per cent, which would correspond to 16 per cent of the protein portion of the mole- 
cule.  Therefore,  the protein was calculated as 6.25  times the Kjeldahl nitrogen content of 
conjugates. The molecular weights of the proteins were assumed to be 45,000 for HEA, 69,000 
for HuSA, and 169,000  for BGG. 
Results for TCA-treated conjugates were: 
PABA- BGG ............................ 
PABA-HuSA ........................... 
PABA-HEA (1) ......................... 
PABA.HEA (2) ......................... 
PABA per mg protein  PABA per mole protein 
#mo~ 
0.675 
0.665 
0.756 
0.815 
114 
46 
34 
37 
DFB conjugates were prepared as previously described (19). 
Induction  of Tolerance.--Guinea  pigs were inoculated intraperitoneally for 8  consecutive 
days with 10 mg of cyclophosphamide (cytoxan)  ~ per day. On the 2nd day and sometimes also 
on the 3rd day of injection of cyclophosphamide, specific antigen in physiologic saline was 
administered intraperitoneally. During the 2 months following injection of the drug, 20 to 40 
per cent of animals in various groups died,  presumably from effects of cyclophosphamide. 
Hence,  the number of animals described in the text as having been inoculated with cyclo- 
phosphamide refers to the number that survived and actually were used in the experiment. 
After the animals lind been allowed to rest for 2 months, protein antigens or their conjugates 
were dissolved in 1 per cent normal guinea pig serum in physiologic saline, emulsified with 
equal volumes of Frennd's adjuvant  (Difco Laboratories, Inc., Detroit), and 0.5 ml of the 
water-in-off emulsion was injected into the four foot-pads. The guinea pigs were immunized 
with 5 to 15 #g of the unconjugated protein or 15 #g of the conjugated protein. 
Skin Tests.--Gninea pigs were skin tested on the flanks with 5 #g of antigen protein. The 
intradermal reactions were measured for areas of induration at both 4 and 18 to 24 hours. 
Antibody Determinatio~.--Guinea pigs were bled by intracardiac puncture and the pres- 
ence of antibody was determined. In passive cutaneous anaphylaxis (PCA), 0.1 ml of a  test 
serum was injected intradermaUy into a  normal guinea pig.  About 3  hours later, the same 
animal was inoculated intravenously with 1 ml of 0.5 per cent Evans blue solution containing 
350 #g antigen protein. The areas of blue skin were examined 30 minutes later and the results 
recorded.  Hemagglutination  titers  were  determined  by  a  modification  of  the  method  of 
Stavitsky (17). Quantitative precipitins were done by a modification of the immunochemical 
procedures of Heidelberger and coworkers (18).  Analysis of antigens and antibodies was also 
conducted by gel diffusion methods (20). 
Homogeneity.--Each  of  the ~/-globulins was  assayed  by agar  diffusion methods against 
hyperimmune antisera from rabbits and guinea pigs and against sera from "control" guinea 
2 Obtained through the courtesy of Dr.  D.  E.  Bebout, Mead Johnson Research Center, 
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pigs used in the experiments on tolerance described below. Agar plates were also prepared for 
tests with SGG and HoGG against rabbit antibodies to the X-globulins (anti-SXG and anti- 
HoXG). Single bands of precipitate developed between HoGG, PGG, and GGG and their 
respective homologous  antisera. Two bands formed between BGG and either rabbit or guinea 
pig anti-BGG, and two bands were detected between SGG and guinea pig anti-SGG. 
1LESLrLTS 
Unresponsiveness to Bovine Gamma Globulin (  BGG) .--F  orty-nine guinea pigs 
were  inoculated  intraperitoneally  with  10  mg  cyclophosphamide  (cytoxan) 
daily for 8  days.  On  the  2nd  day,  20  to 40 mg BGG was also administered 
intraperitoneally. Forty-three control animals receiving only cyclophosphamide 
TABLE I 
Response of Guinea Pigs Inoculated Intraperitoneally with 80 mg Cydophosphamide 
and 20 to 50 mg BGG and g Months Later Administered 15 Izg BGG or a 
tteterotogous Antigen in Freund's Incomplete Adjuvant in Foot-pads* 
Sensitizing  antigen injected 
~GG .................................. 
PABA.BGG ............................ 
PAAA.BGG ............................ 
HoGG ................................. 
Definite  response to 
homologous antigen 
#er cent 
11/49:~  22 
27/32  84 
4/4 
1s/is 
Response  to BGG 
#er cen~ 
4/16  25 
1/4 
o/is 
* All control animals inoculated with cyclophosphamide and 2 months later with one of 
the specific  antigens had antibodies to the injected antigen. 
No. of animals with circulating antibody (by PCA) 
No. of animals tested 
were included in the study. Two months later, all guinea pigs were inoculated 
in the foot-pads with 15 #g BGG in Freund's incomplete adjuvant.  Groups of 
animals were bled at frequent intervals and the sera were assayed for anti-BGG 
antibody by passive cutaneous anaphylaxis. 
All  control  animals  developed  detectable  antibody  on  about  the  9th  day 
after  challenge.  Of the  49  guinea  pigs administered  antigen  with  cyclophos- 
phamide, 32 were unresponsive during the test period, i.e. 60 days after inocula- 
tion, and 6 formed questionable amounts of antibody for a  very brief period. 
Thus,  65  per  cent  of the  guinea  pigs remained unresponsive  to  the  protein, 
BGG. 
When  guinea pigs  treated  with  20  to  50  mg  BGG and  80  rag  cyclophos- 
phamide  were  inoculated  in  the  foot-pads with  15  /zg  PABA.BGG,  PAAA. 
BGG, or HoGG in Freund's incomplete adjuvant, antibody was readily formed 
to the secondary antigen,  although the animals still did not respond to BGG 
(Table  I).  Thus,  animals,  unresponsive  to a  protein  (BGG)  after treatment S.  B.  SALVIN  AND  R.  ~'.  SMITH  855 
with cyclophosphamide and challenged subsequently with an altered protein 
(such as PABA-BGG), developed antibody to the altered protein, but tended 
to retain the unresponsiveness to the original protein. 
Unresponsiveness  to  the  Conjugate  PABA .BGG.--Fifty-seven guinea  pigs, 
treated as above with cyclophosphamide, were inoculated intraperitoneally on 
the 2nd day with 40 nag PABA. BGG. Thirty-four guinea pigs were adminis- 
tered  cyclophosphamide  without  any  additional  antigen.  About  2  months 
later,  all animals were inoculated in the foot-pads with  15  pg PABA-BGG, 
and bled at frequent intervals for antibody analysis. 
TABLE II 
Response of Guinea Pigs Inoculated Intraperitoneally with 80 mg Cydopkospkamide 
and 40 rng PABA .BGG and 2 months later Inoculated in the Foot-pads with 15 
I~g PABA .BGG or a Variant in Freund's Incomplete Adjuvant 
Sensitizing antigen injected  Response to homologous  antigen  Response to PABA.BGG 
PABA.BGG  ............................ 
BGG .................................. 
PAAA-  BGG  ............................ 
DFB.BGG ............................. 
PABA.HEA  ............................ 
PABA-HoGG  ........................... 
PABA.  PGG ............................ 
PABA. SGG ............................ 
PASA.BGG  ............................ 
0/57* 
31/31 
24/27 
21/21 
19/19 
11/23 
11/12 
O/lO 
3/12 
0/57 
0/31 
O/27 
0/21 
0/19 
0/23 
o/12 
O/lO 
0/12 
,  No. of  animals with circulating  antibody (by PCA and hemagglutination) 
No. of  animals tested 
Not one of the 57 animals, administered cyclophosphamide and PABA. BGG 
simultaneously and later reinoculated with PABA.BGG, developed antibody 
detectable by passive cutaneous anaphylaxis or hemagglutination with PABA- 
HEA or PABA. HuSA as antigens. Also, none showed delayed hypersensitivity 
on skin test with homologous conjugate. In contrast, all controls formed circu- 
lating anti-PABA. BGG antibody beginning about the 12th day after challenge. 
Animals rendered unresponsive to the conjugate PABA. BGG were inoculated 
in  the foot-pads with one of the following variants in  Freund's incomplete 
adjuvant: BGG, PAAA. BGG, PASA. BGG, PABA. HEA, DFB. BGG, PABA. 
HoGG, PABA. PGG, and PABA. SGG (Table II). In all cases but two (PABA- 
SGG and PASA. BGG), antibody was formed to the variation of the PABA- 
BGG conjugate,  although challenge of the unresponsive state  with PABA. 
HoGG produced antibody in only 48 per cent of the animals. The exceptions 
wherein antibody could not be detected after challenge occurred in animals 
given  PABA-SGG  or  PASA.BGG.  SGG  has  extensive  cross-reaction  with 856 
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FIG. 1.  Hemagglutination titers (a) in guinea pigs unresponsive to PABA-BGG and later 
challenged in foot-pads with 15 #g PAAA.BGG in Freund's incomplete adjuvant,  or (b)  in 
controls challenged in foot-pads with 15 #g PAAA.BGG in Freund's incomplete adjuvant. S.  B.  SALVIN  AND  R.  F.  SMITH  857 
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FIG. 2.  Hemagglutination titers (a) in guinea pigs unresponsive  to PABA. BGG and chal- 
lenged in foot-pads with 15/~g BGG in Freund's incomplete adjuvant, or (b) in controls chal- 
lenged in foot-pads with 15/~g  BGG in Freund's incomplete adjuvant. 858  SPECIFICITY  OF  ALLERGIC  REACTIONS.  VII 
anti-BGG, whereas HoGG and PGG do not. The tolerant animals that formed 
antibody to the variant of the  conjugate still retained  their  original specific 
unresponsiveness. Also, guinea pigs that formed antibody to a variant of PABA. 
BGG but were still unresponsive to the  PABA.BGG did not form antibody 
to the  PABA.BGG when  they were reinoculated in  the foot-pads with  that 
antigen  in  incomplete  adjuvant.  The  controls  receiving  cyclophosphamide 
alone formed antibody to each of the different antigens injected. 
TABLE III 
Response  of Guinea Pigs Inoculated  Intraperitoneally  with 80 mg Cydophosphamide 
and 40 mg PABA .HoGG and Subsequently  Exposed  to a Heterologous Protein 
or Conjugate in Freund's  Incomplete  Adjuvant 
Sensitizing antigen injected 
PABA.HoGG ............................................ 
HoGG ................................................... 
PAAA. HoGG  ............................................ 
PABA.BGG ............................................. 
Response to homologous 
antigen*  (by PCA) 
0/12 
10/11 
7/12 
9/lo 
* None of the animals showed anti-PABA.HoGG antibody at any time during the post- 
challenge period of 60 days. 
TABLE IV 
Ddayed and Arthus Hypersensitivity  in 14g Guinea Pigs Sensitized  in the Foot-pad~ 
with 15 ~g Gamma Globulin of One Species  and Skin-tested  on Days 5 to 20 witk 
Four Gamma Globulins 
Skin-testing  antigen 
Arthus response 
SGG 
Sensitizing antigen  Delayed  response 
BGG  HoGG  PGG  SGG 
HoGG ...................... 
PGG  ........................ 
sGo ........................  :l  ;l-J-t; 
BAG_6 Ho___~ PG___~_a 
+  + 
+1+1+1+  +[-[±[+ 
Animals unresponsive to PABA. BGG formed antibodies  to BGG, PAAA- 
BGG, and  PABA.HoGG. During  the first  14  days,  the anti-PAAA  titers  of 
the  sera from guinea pigs unresponsive  to PABA.BGG and  challenged  with 
PAAA.BGG were approximately the same as the control animals challenged 
with PAAA. BGG but not made unresponsive to PABA. BGG (Fig.  1). There- 
after,  the anti-PAAA titers of the  control animals were higher  than  those of 
the guinea pigs unresponsive to PABA-BGG. Titers of sera from animals un- 
responsive to PABA. BGG and challenged with either BGG (Fig. 2) or PABA. S. B.  SALVIN  AND  R. ]~. SMITH  859 
HoGG were lower than the titers of control animals which had not been made 
unresponsive to PABA.BGG. Antigen-antibody studies in agar did not show 
cross-reactions  between  rabbit  or guinea pig  anti-BGG and  PABA.BGG  or 
between  anti-PABA.BGG  and  PAAA.BGG,  but  did  show  cross-reactions 
between anti-PABA. BGG and PABA- HoGG. 
Unresponsiveness  to  the  Conjugate  PABA .HoGG.--Forty-five  guinea  pigs 
were  inoculated  intraperitoneally  daily  for  8  days  with  10  mg  cyclophos- 
phamide,  and  on  the  2nd  day with  40 mg PABA.HoGG.  Fifty-one control 
guinea pigs were inoculated daily with  10 mg cyclophosphamide. All animals 
TABLE V 
Response of Guinea Pigs Inoculated Intraperitoneally with 80 mg Cydophosphamide 
and 20 mg BGG, and Subsequently Challenged  with BGG or One of Four 
Heterologons Proteins 
Response to homol-  Sensitizing antigen  ogous antigen  Response to BGG 
BGG .................................. 
HoGG ................................. 
PGG ................................... 
GGG .................................. 
SGG ................................... 
Controls 
BGG .................................. 
HoGG ................................. 
PGG ................................... 
GGG .................................. 
SGG ................................... 
2/13" 
is/as 
13/13 
14/14 
lS/1s 
11/11 
11/11 
lO/lO 
lO/lO 
lO/iO 
0/15 
13/13 
12/14 
11/15 
1/11 
9/9 
10/10 
lO/1O 
* No. of guinea pigs with circulating antibody (by PCA) 
No. of guinea pigs tested 
were inoculated 2 months later in the foot-pads with 15/~g antigen in Freund's 
incomplete  adjuvant  (Table  III). 
Again,  all  animals  were  unresponsive  to  the  original  conjugate,  PABA- 
HoGG.  Any modification  of  this  antigen  for  the  challenge,  such  as  HoGG, 
PAAA-HoGG, or PABA.BGG, resulted in the formation of antibody to the 
antigen  used  for  challenge,  although  the  original  unresponsiveness  to  the 
PABA.HoGG  remained.  Control  animals  all  formed  antibody  to  the  chal- 
lenging antigen. 
Unresponsiveness  to  Gamma  Globulins.--The  immunologic  cross-reactions 
of gamma globulins of related mammalian species have been studied by meth- 
ods involving quantitative precipitation (21). Other studies have been made on 
the relationship of protein antigens of different species with the aid of hyper- 
sensitivity reactions (15). Cross-reacting serum albumins have also been studied 
by examination of the loss of the tolerant state in rabbits injected with one of 860  SPECIFICITY  OF  ALLERGIC  REACTIONS.  VII 
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the proteins (22). Herein, animals made unresponsive to bovine gamma globulin 
were  studied for  their  capacity to  form antibodies  to  related  heterologous 
globulins. 
In order  to determine the extent of cross-reactions in delayed and Arthus 
hypersensitivity between BGG, HoGG, SGG, and PGG, 148  guinea pigs were 
sensitized in the foot-pads with 15 gg of one antigen in Freund's incomplete 
adjuvant and skin tested with all four antigens at intervals from 5 to 20 days 
TABLE  VI 
Reactions  in Agar Gd between Rabbit  (Ra) and Guinea Pig (GP) Antibodies  and 
H eter  olog  ou~ "y-Globulins 
Antibody 
Ra anti-BGG ........................... 
GP anti-BGG  .......................... 
Ra anti-GGG .......................... 
GP anti-GGG .......................... 
Ra  anti-SGG .......................... 
GP  anti-SGG .......................... 
Ra  anti-PGG  .......................... 
GP  anti-PGG  ......................... 
Ra anti-HoGG.. 
GP anti-HoGG ........................ 
Antigen 
G( 
--{ 
+ 
+ 
--t 
--4 
+ 
+ 
+ 
-4- 
~GC 
F-4 
t-A 
}--t 
-4- 
-4- 
,G(  PGG 
~  -4- 
~ 
P~  ± 
+  ++ 
+  ++ 
+  + 
±  -4- 
HoGG 
-4- 
+ 
-4- 
+ 
-4- 
++ 
++ 
-I-q-, strong; "4-, weak; -4-, questionable;  --, negative. 
after inoculation. Each guinea pig was tested only once with the group of anti- 
gens. The patterns of reactions  (Table IV) indicate the di~erences in response 
for delayed vs.  Arthus types of hypersensitivity. 
Seventy guinea pigs  were inoculated with cyclophosphamide  as  described 
above. On the 2rid day, 20 mg BGG was injected intraperitoneally. Two months 
later, the animals were inoculated in the foot-pads  with 15 #g of one of the 
following  heterologous  proteins  in  Freund's  incomplete  adjuvant:  HoGG, 
GGG, PGG, and SGG  (Table  V).  For a period  of 2 months after challenge, 
only 2 of 13 guinea pigs administered cyclophosphamide and BGG developed 
anti-BGG antibodies detectable by PCA. In contrast, all 15 animals challenged 
with HoGG developed  anti-HoGG antibodies,  and none  developed  definite 
anti-BGG antibody. Of the 13 guinea pigs challenged with PGG, all formed 
anti-BGG and anti-PGG antibodies. Although all animals unresponsive to BGG 862  SPECIFICITY OF  ALLERGIC REACTIONS. VII 
formed antibodies to PGG, the antibody fiters to the PGG were slightly lower 
than those of the control animals (Fig. 3). Of the animals inoculated with GGG 
or SGG some remained unresponsive to BGG, although the majority did form 
anti-BGG antibody.  The control animals receiving PGG,  SGG,  and  GGG all 
formed antibodies to both the homologous antigen and BGG. Thus, it appears 
that those antigens closely related to BGG tend to terminate the unresponsive- 
ness to BGG. 
In  studies  on antigen-antibody  reactions  in  agar  gel,  hyperimmune  rabbit 
TABLE VII 
Quantitative Precipitins between  Guinea Pig Antisera and "y-Globulins of Various 
Species 
Antibody 
Normal 
anti-BGG ........................... 
anti-SGG ............................ 
anti-GGG ............................ 
anti-PGG ............................ 
anti-HoGG ........................... 
Tolerant 
anti-BGG ............................ 
anti-SGG ............................ 
anti-GGG ............................ 
anti-PGG ............................ 
anti-HoGG ........................... 
Antigen 
BGG  SGG 
0.96"[  0.52 
0.59  [  1.00 
0.25  0.30 
0.36  0.28 
0.02  0.04 
<0.01  [  0.02 
0.20[  0.25 
0.08[  0.03 
0.11  0.04 
<0.01  <0.01 
i 
GGG 
0.46 
0.94 
0.36 
0.28 
0.04 
0.05 
0.15 
0.02 
0.07 
0.02 
PGG 
0.09 
0.01 
0.02 
0.74 
0.11 
0.10 
0.03 
0.03 
0.59 
<0.01 
HoGG 
<0.01 
0.01 
0.01 
0.19 
1.3 
<0.01 
0.04 
0.07 
0.06 
>0.25 
* Mg antibody protein precipitated  per ml serum. 
anti-~,/-globulins  contained  antibodies  to all  five  of the  "/-globulins  in  every 
case  but  one,--anti-PGG  did not develop detectable  precipitates  to  HoGG. 
The bands  of precipitate  between  anti-SGG and  PGG or HoGG were barely 
detectable.  Guinea  pig  antisera  did  not  have  cross-reacting  antibodies  for  a 
number  of combinations  (Table  VI). 
Quantitative precipitin analyses were made with sera of normal guinea pigs 
immunized to each one of the five antigens and with sera of guinea pigs made 
tolerant to BGG and then immunized with the same antigens. All the bleedings 
were done 5 weeks after the immunizing inoculation.  Sera from single animals 
were used in the cases of tolerant guinea pigs sensitized to PGG and SGG and 
of normal guinea pigs sensitized to PGG, SGG, and GGG. The rest were pools 
composed of sera from 3  animals in the same experimental  group.  Since only 
2 or 3 ml of serttm of each type was available,  the amount of antigen and anti- S.  B.  SALVIN  AND  R.  F.  SMITH  863 
body per  tube and the number of tubes for each precipitin curve had to be 
reduced  to a  minimum. Because  of these  limitations,  the  accuracy of these 
results does not compare with that of the conventional precipitin method (18), 
but the points obtained were not scattered and fell on curves of the usual shape. 
In the present case, 0.1 ml of serum and 0.1 ml of antigen were mixed in 
10 x  75 mm culture tubes, precipitates were washed only twice with 0.2  ml 
of cold saline, and the protein determinations were obtained by a modification 
of  the  bromsulphthalein  (BSP)  method  (23).  Antigen-antibody precipitates 
were dissolved in 0.1 ml of M/4 acetic acid, mixed with 0.5 ml of 0.025 per cent 
BSP in 0.25 M citric acid, and centrifuged; 0.2 ml of the superuatant was mixed 
with 3  ml of ~/10  NaOH  and  optical density was  determined at  580  m/~. 
Amounts of protein were read from a standard curve based on BGG. 
With total precipitate plotted against micrograms of antigen per milliliters 
of serum, the point of maximum precipitate was determined by inspection, and 
the total antigen in the tube subtracted from the total precipitate. The error 
in these figures is probably about 10 per cent and antibody concentrations of 
0.02 mg/ml or less are of doubtful significance. In general, the results are similar 
to those obtained with Arthus reactions and PCA (Table VII). 
DISCUSSION 
Adult  guinea pigs  may be  made unresponsive  to  a  variety of protein  or 
hapten-protein  antigens  by  simultaneous  intraperitoneal  administration  of 
cycIophosphamide and a  specific  heterologous protein  or protein  conjugate. 
The unresponsiveness)  developing after treatment with cyclophosphamide has 
a  specificity different from that characteristic of delayed hypersensitivity or 
circulating antibody. A change in either the protein or hapten portions of the 
conjugate molecule resulted in the formation of delayed hypersensitivity and 
circulating antibody, although the unresponsiveness to the original conjugate 
persisted. When a protein closely related to and cross-reacting with the original, 
as determined by in vitro precipitation (e.g.  BGG and SGG) was substituted 
in the conjugate, unresponsiveness persisted to both proteins. When an animal 
was made unresponsive to one protein (e.g. BGG) and was subsequently chal- 
lenged with a  protein  (such as SGG)  which shares many, but not all,  of its 
determinant groups, antibody developed to both antigens. When a guinea pig 
was made unresponsive to one protein (e.g. BGG) and challenged with a protein 
with which it has very few determinant groups in common (e.g.  HoGG), anti- 
body formed to the challenging protein, but only in very small amounts, if at 
all,  to  the  original protein. 
In previous studies of others with altered antigens in rabbits made unresponsive to 
proteins  or protein  conjugates, varied results were obtained.  Thus, rabbits rendered 
tolerant at birth by intraperitoneal  injection of bovine serum albumin (BSA) did not 
develop antibody to subsequent  challenges of p-sulfanilic acid coupled to BSA (24). 864  SPECIFICITY OF ALLERGIC REACTIONS. VII 
The  animals  were  challenged  intravenously  with  conjugated  BSA  in  saline,  and 
antibody was determined by rate of elimination of radioactive antigen. In another set 
of experiments (25), rabbits, made unresponsive at birth by intraperitoneal injections 
of 110 to 140 mg human serum albumin (HuSA), were challenged intravenously with 
2.5  mg p-sulfanilic acid coupled to HuSA, and antibody formation was determined 
by hemagglutination with tannic acid-treated red blood cells. Antibody could not be 
detected in any of 15 rabbits inoculated at birth with HuSA. Similarly, adult guinea 
pigs rendered unresponsive to dinitrochlorobenzene (DCB) by "gastric feeding" did 
not respond to inoculation in the foot-pads with specific contact hapten in Freund's 
incomplete adjuvant (3, 26). When mycobacteria were incorporated into the sensitizing 
emulsion, the state of unresponsiveness was less apparent. When guinea pigs gastric- 
fed with DCB were later inoculated in the foot-pads with an in vitro conjugate of the 
hapten combined with a heterologous protein and suspended in incomplete adjuvant, 
an immune response occurred both to the hapten and to the protein carrier.  Again, 
guinea pigs, inoculated intraperitoneally with 15 mg hen egg albumin (HEA) in utero, 
failed as adults to respond to stimulation in the foot-pads with  15 ~g PABA.HEA 
in Freund's incomplete adjuvant (11). The specificity of the unresponsiveness, there- 
fore, seemed to be associated essentially with the protein moiety. 
On the contrary, when the antigenic challenge was administered in Freund's com- 
plete adjuvant, a breakdown of tolerance was observed in many cases. When newborn 
rabbits were inoculated with 500 mg HuSA (27), given intraperitoneally in saline and 
subcutaneously  "in  emulsion,"  2  of  6  animals  developed  antibodies  (detected  by 
hemagglutination)  after  subsequent  intravenous  challenge with  6  to  15  mg HuSA 
coupled by diazotization with p-sulfanilic acid (11 to 16 groups per protein molecule). 
In later work (28), another rabbit, after having been made tolerant to HuSA, formed 
antibody  to  PASA.HuSA.  Rabbits  made  unresponsive  to  BSA  by  several  sub- 
cutaneous  injections  totaling  500  mg during  the  first  5  days after  birth  lost  this 
tolerance after challenge with 3 weekly injections each of 25 mg arsanil-sulfanil-BSA 
in Freund's complete adjuvant (29). Rabbits unresponsive to BSA and subsequently 
challenged  subcutaneously  with  either  sulfanil-BSA  or  arsanil-BSA  in  Freund's 
complete adjuvant formed antibody to the hapten,  but not to the native protein. 
Apparently, when an animal unresponsive to a protein is challenged with a conjugate 
of the specific protein, antibody to the conjugate develops. If the challenge is made 
sufficiently strong by incorporation into complete adjuvant or by exposure  of the 
animal to repeated doses,  not only is antibody formed to the new conjugate but also 
the unresponsiveness to the original protein or conjugate may be eliminated. Further 
minor variations may exist depending on such factors as the species  of experimental 
animal, the mode of induction of unresponsiveness, the route and severity of challenge, 
the method of conjugate synthesis, and the vehicle for antigen injection. 
Unresponsiveness in rabbits following neonatal injections of BSA was terminated 
by a series  of injections of an albumin distantly related to BSA, such as HuSA, but 
persisted when the animals were challenged subcutaneously with two series  of injec- 
tions of 110 mg each of a closely related protein, such as sheep serum albumin (22). 
These  results  are  somewhat  different  from  those  described  herein  in  guinea  pigs. 
Unresponsiveness  to  BGG,  induced  in  adults  with  cyclophosphamide,  tended  to 
persist after challenge in the foot-pads with  15  t~g of  the  distantly  related antigen S.  B.  SALVIN AND R.  F.  SMITH  865 
HoGG in Freund's incomplete adjuvant, but was terminated when the guinea pig was 
similarly challenged with the closely related antigen, SGG or GGG. 
Recently,  five  types of immunological  tolerance  were  recognized  (30),  although 
definite evidence does not exist as to whether they are or are not all part of the same 
basic mechanism: (a)  that produced by exposure to antigen very early in life,  (b) 
that produced by exposure of an animal to a high dose of ionizing radiation followed 
very shortly by exposure tO antigen, (¢) that produced by exposure of adult rabbits to 
high doses of soluble protein antigens, (d)  that induced  in adult guinea pigs by oral 
administration of certain simple chemicals or contact haptens, and (e) that produced 
by exposure  of adult mice to high doses  of pneumococcal polysaccharide which  in 
lower doses would have induced immunity. In these t~jrpes of unresponsiveness,  the 
development of the capacity to react to an antigen is delayed and, in the continued 
presence of the antigen, is postponed indefinitely.  The animal must be exposed to the 
antigen before the capacity to react against it becomes established.  The animal is 
retarded  in  its  immunologic development  toward  a  specific  antigen  or  antigens, 
although  immunologic  responses  in  general are normal. The antigen  is eliminated 
from the blood stream in a "non-immune" pattern. 
Variations in or modifications  of the classical concept of unresponsiveness  have been 
reported. Recently, for example, a partial inhibition of "delayed" hypersensitivity in 
mice was characterized as "immunologic unresponsiveness" (31). Mice sensitized with 
a  single  subcutaneous injection of 0.25 mg hen  egg albumin in Freund's complete 
adjuvant were skin tested 4 days later, and an inhibition of subsequent skin tests read 
at 24 hours in the presence of specific anti-HEA antibody was noted, although the 
3-hour readings  were the same as those of the controls.  Whether such specific but 
partial  desensitization  of  a  skin  response  should  be included  in  immunologic  un- 
responsiveness  is doubtful, especially  since complete and long-lasting suppression  of 
the immune response,  including  delayed hypersensitivity, has been established (2, 3, 
7, 11, 32, 33). Such reactions as inhibition of antibody formation to a conjugate in the 
presence of antibody to homologous protein was not and should not be considered  as 
immunologic tolerance (34). Also, since immunologic unresponsiveness  is specific, non- 
specific suppression  of the immune response should not be included. 
The  specificity of unresponsiveness,  as demonstrated  in  adult  guinea pigs 
after treatment with cyclophosphamide, is different from other phases of the 
immune process,  such  as  delayed  hypersensitivity  and  circulating  antibody. 
Where  the  specificity  of  circulating  antibody  is  oriented  primarily  toward 
groupings of small molecular size and where the specificity of delayed hyper- 
sensitivity is  directed  toward  groupings  of large  molecular size  (14-16,  35), 
the specificity of unresponsiveness may be oriented toward the whole antigen 
molecule. If unresponsiveness is considered to be associated with an early phase 
in the immune process and if delayed hypersensitivity is an intermediate phase, 
then a  transition  in specificity occurs in the maturation of the immunogenic 
cells from an orientation toward the entire antigen molecule to an orientation 
toward small molecular configurations. This progression in specificity may be 
explained in several ways. For example, as the immune process passes through 866  SPECIFICITY  OF  ALLERGIC  REACTIONS.  VII 
various cell types from the reticular cell to the mature plasma cell, an actual 
alteration or transformation in the recognition mechanism of the cell may exist, 
so that each cell type can identify only certain molecular types or sizes in the 
antigen. A second mechanism may be based on the gradual breakdown of the 
foreign protein antigen by cellular enzymes and on the recognition of these 
products as the antigen. Thus, early in the immune process,  when cellular en- 
zymes have had little opportunity to alter the original antigen, the specificity 
is oriented primarily toward the whole original antigen, as in immunologic un- 
responsiveness. As the antigen is carried from one daughter cell to another and 
is metabolized by the cell enzymes, the molecular size of the antigen decreases. 
If each cell phase recognizes and responds to the antigen fragment within, then, 
as the immune process progresses,  the antigenic determinants become smaller 
and smaller. Thus, the specificity of a  cell changes because of a  modification 
in the antigen molecule within the cell and not because of a change in the recog- 
nition apparatus  of a  cell  type. 
The possibility exists that unresponsiveness may be initiated at several early 
phases of the immune process and that the initiation at each different stage may 
produce a specificity slightly different from the others. Thus, unresponsiveness 
induced by cydophosphamide in adults may be associated with a slightly differ- 
ent stage of the immune mechanism than that produced in newborns. At any 
rate, the phase or phases associated with immunologic unresponsiveness does 
precede  the  phases  associated  with  delayed  hypersensitivity and  antibody 
formation, since the latter two are both suppressed in the process. 
In adult guinea pigs treated with cyclophosphamide, the more antigenic the 
protein or protein conjugate, the greater is the diflficulty in the induction of 
unresponsiveness.  Thus,  with  similar  procedures,  routes  and  doses,  unre- 
sponsiveness develops more readily in animals with HoGG as antigen than with 
BGG as antigen, and more readily with BGG (36) than with HEA. Also, con- 
jugates of a  protein induce immunologic unresponsiveness more readily than 
does the protein itself, such as PABA.BGG vs.  BGG. 
SlY~a~RY 
Adult guinea pigs were made unresponsive to a  heterologous protein  (e.g. 
bovine gamma globulin, or BGG) or a hapten-protein conjugate (e.g.  p-amino- 
benzoic  acid-bovine  gamma  globulin,  or  PABA-BGG)  by  intraperitoneal 
injection of 80 mg cyclophosphamide and the specific antigen. This immunologic 
unresponsiveness developed to the specific antigen administered simultaneously 
with  the  cyclophosphamide, and  not  to  any variants.  Thus,  animals unre- 
sponsive  to  PABA.BGG remained unresponsive  to  the  original  antigen  on 
challenge with a variant, but formed delayed hypersensitivity and circulating 
antibody  to  the  variant.  The  specificity of  immunologic unresponsiveness, S.  B.  SALVIN  AND  R.  F.  SMITH  867 
therefore, seems more closely related to the whole antigen molecule than does 
delayed hypersensitivity. 
The authors acknowledge  the technical assistance of Jane Nishio and Leroy F. Peel. 
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